Biogen Alzheimer’s drug and the battle over dementia treatment of the future - Earth News Report
In this articleLLYBIIBAduhelm by BiogenSource: BiogenThe FDA's approval of Biogen's Alzheimer's drug Aduhelm was a landmark moment in the life of Dr. Paul Aisen. The director of the Alzheimer's Therapeutic Research Institute at USC has spent the past three decades focused on treating the neurodegenerative disease, and in recent years helped shepherd this particular drug
